NCT03687528

Brief Summary

At the emergencies rooms, patients with head trauma meeting one of the NICE criteria, which include antiplatelet inhibitors treatment, are considered as patients with a risk of cerebral haemorrage and are taken systematically for a CT-scanner. However, there are more and more antiplatelet inhibitor's patient with minor head injury traumas seen at the emergencies room and the efficiency of this NICE criteria is controversial on litterature. This study aims to determine that the absence of no other NICE criteria than antiplatelet inhibitors is a sufficient condition to eliminate a cerebral haemorrhage for patients with head injury traumas, and conversely, that antiplatelet inhibitors treatment would not be by itself an indication for a CT-scanner.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3,200

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Jun 2020

Longer than P75 for all trials

Geographic Reach
1 country

12 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Jun 2020Dec 2026

First Submitted

Initial submission to the registry

September 26, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 27, 2018

Completed
1.7 years until next milestone

Study Start

First participant enrolled

June 15, 2020

Completed
6.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

January 5, 2026

Status Verified

December 1, 2025

Enrollment Period

6.5 years

First QC Date

September 26, 2018

Last Update Submit

December 31, 2025

Conditions

Keywords

emergenciesplatelet inhibitorsminor head injury traumaCT-scan

Outcome Measures

Primary Outcomes (1)

  • Existence of a cerebral haemorrhage at the CT-scanner.

    Cerebral haemorrhage seen at the CT-scanner.

    1 day

Secondary Outcomes (6)

  • Neurosurgeries' rate after one month

    1 month

  • Existence of a cerebral haemorrhage associated to death

    1 month

  • Existence of a cerebral haemorrhage associated to neurosurgery

    1 month

  • Existence of a cerebral haemorrhage associated to hospitalization with more than 24h of intubation

    1 month

  • Existence of a cerebral haemorrhage associated to more than 2 nights at hospital

    1 month

  • +1 more secondary outcomes

Study Arms (1)

Patient with minor head injury trauma

The emergency protocol for antiplatelet inhibitors treated patient with head injury trauma and meeting others NICE criteria involves a clinical exam followed by a CT-scanner.

Radiation: CT-scanner

Interventions

CT-scannerRADIATION

After a clinical exam, patient have a CT-scanner to check any cerebral haemorrhage.

Patient with minor head injury trauma

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Major patients undergoing antiplatelet inhibitors treatment which are reported at the clinical exam as having a head injury trauma. These patients don't meet another NICE criteria : * neurological focal deficit * amnesia for more than 30 min * glasgow score less than 15 after 2 hours * loss of consciousness associated with either a high velocity or an age \> 65 years old * suspicion of a cranial open fracture * fracture on cranial basis * more than 1 vomit * post-traumatic convulsion

You may qualify if:

  • At least 18 years old
  • Patient with a head injury trauma, described by the patient or seen at the clinical exam
  • Glasgow score between 13 and 15 at the clinical exam
  • Current treatment with antiplatelet inhibitors
  • Informed non opposition form signed

You may not qualify if:

  • Absence of CT-scanner
  • Patients with double anti-platelet aggregation
  • Patients on anticoagulants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

CHU d'Angers

Angers, France

RECRUITING

CHU Brest

Brest, France

RECRUITING

CH Chartres

Chartres, France

RECRUITING

CH Le Mans

Le Mans, France

RECRUITING

CH Bretagne Sud, Lorient

Lorient, France

RECRUITING

CHU de Nantes

Nantes, France

RECRUITING

CHU de Poitiers

Poitiers, France

RECRUITING

CH Bretagne Sud - Quimperlé

Quimperlé, France

RECRUITING

CHU de Rennes

Rennes, 35033, France

RECRUITING

CH de Saint Brieuc

Saint-Brieuc, France

NOT YET RECRUITING

CH de Saint Malo

St-Malo, France

RECRUITING

CH Bretagne Atlantique

Vannes, France

NOT YET RECRUITING

MeSH Terms

Conditions

Emergencies

Interventions

Tomography Scanners, X-Ray Computed

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Equipment and Supplies

Study Officials

  • Paul-Georges REUTER, Pr

    CHU Rennes

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 26, 2018

First Posted

September 27, 2018

Study Start

June 15, 2020

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

January 5, 2026

Record last verified: 2025-12

Locations